MCP
HZNP

Mirador Capital Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Mirador Capital Partners’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,661
Closed -$308K – 211
2023
Q3 		$308K Buy
2,661
+1
+0% +$107 0.07% 147
2023
Q2 		$274K Hold
2,660
– – 0.06% 163
2023
Q1 		$290K Sell
2,660
-200
-7% -$22.1K 0.07% 153
2022
Q4 		$325K Buy
+2,860
New +$238K 0.08% 146
2022
Q3 		– Sell
-2,885
Closed -$230K – 205
2022
Q2 		$230K Sell
2,885
-50
-2% -$4.74K 0.05% 171
2022
Q1 		$309K Sell
2,935
-50
-2% -$4.87K 0.06% 175
2021
Q4 		$322K Sell
2,985
-577
-16% -$62.9K 0.07% 181
2021
Q3 		$390K Buy
3,562
+27
+0.8% +$2.8K 0.09% 162
2021
Q2 		$331K Buy
3,535
+60
+2% +$5.52K 0.07% 170
2021
Q1 		$320K Sell
3,475
-15
-0.4% -$1.27K 0.08% 145
2020
Q4 		$255K Hold
3,490
– – 0.07% 155
2020
Q3 		$271K Sell
3,490
-110
-3% -$7.57K 0.08% 146
2020
Q2 		$200K Buy
+3,600
New +$154K 0.07% 151
2020
Q1 		– Sell
-16,455
Closed -$596K – 188
2019
Q4 		$596K Buy
+16,455
New +$505K 0.24% 92

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mirador Capital Partners's HZNP Position: Q4 2023 in Review

Mirador Capital Partners sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 2,661 shares — an estimated $308K sold.

Mirador Capital Partners first reported a position in HZNP in Q4 2019 and held it in 14 quarters. The position peaked at $596K in Q4 2019. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Mirador Capital Partners reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Mirador Capital Partners sold 2,661 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $308K.
  • Mirador Capital Partners first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2019 and held it in 14 quarters.
  • Mirador Capital Partners's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $596K in Q4 2019.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Mirador Capital Partners's 13F filing for Q4 2023, filed 19 Jan 2024.